The principal objective of the proposed research is to elucidate the mechanisms of regulation of nitric oxide (NO) production by NO synthase in mammalian cells. The field of NO research has virtually exploded in recent years and NO, one of the simplest molecules in nature, has developed into one of the most ubiquitous and multifaceted biological mediators in physiology and pathophysiology. In view of the widespread actions of endogenously generated NO as a vasodilator, inhibitor of platelet and leukocyte function, neurotransmitter in nonadrenergic-noncholinergic neurons, and pathophysiological mediator of target cell injury, the biosynthesis and metabolism of NO are critical processes that require understanding. NO is chemically labile in biological tissues and, therefore, the factors that influence the biological actions of NO will depend largely on the factors that affect the production of NO. The central hypothesis is that the biosynthesis of NO by vascular smooth muscle and endothelial cells, alveolar macrophages, and hepatocytes is tightly regulated by endogenous factors influencing both the enzymatic activity and transcriptional expression of NOS. Recent studies from this laboratory indicate that NOS activity can be altered by NO, nitroso compounds, tetrahydrobiopterin availability, and redox agents, and that compounds which interfere with the activation of nuclear factor kappa B (NF-kB) inhibit expression of inducible NOS in cytokine-activated macrophages. Additional experiments indicate that NO can down-regulate the transcription of mRNA for inducible NOS. Therefore, the proposed studies focus on the regulation of NOS activity and expression in mammalian cells.
Five specific aims are proposed to achieve the objective: (1) to elucidate the mechanism by which NO inhibits neuronal and endothelial NOS; (2) to determine the reasons why macrophage inducible NOS is resistant to the inhibitory action of NO; (3) to elucidate the mechanism(s) by which calmodulin promotes the catalytic reaction of various isoforms of NOS; (4) to determine the conditions required for the production of reactive oxygen species by NOS isoforms; and (5) to elucidate the roles for NF-kB and reactive oxygen species as mediators of early response gene activation in the expression of inducible NOS in macrophages and hepatocytes. The proposed research represents a continuing long-term effort to understand the biological factors that influence the actions of NO in mammalian cells in both health and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040922-08
Application #
2430672
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1990-04-01
Project End
1999-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
8
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Garban, Hermes J; Marquez-Garban, Diana C; Pietras, Richard J et al. (2005) Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci U S A 102:2632-6
Garban, Hermes J; Buga, Georgette M; Ignarro, Louis J (2004) Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation. J Cardiovasc Pharmacol 43:638-44
Jacobs, Aaron T; Ignarro, Louis J (2003) Nuclear factor-kappa B and mitogen-activated protein kinases mediate nitric oxide-enhanced transcriptional expression of interferon-beta. J Biol Chem 278:8018-27
Jacobs, Aaron T; Ignarro, Louis J (2003) Cell density-enhanced expression of inducible nitric oxide synthase in murine macrophages mediated by interferon-beta. Nitric Oxide 8:222-30
Ignarro, Louis J; Byrns, Russell E; Trinh, Kim et al. (2002) Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms. Nitric Oxide 7:75-82
Bauer, P M; Buga, G M; Fukuto, J M et al. (2001) Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J Biol Chem 276:34458-64
Bauer, P M; Buga, G M; Ignarro, L J (2001) Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide. Proc Natl Acad Sci U S A 98:12802-7
Jacobs, A T; Ignarro, L J (2001) Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem 276:47950-7
Wei, L H; Morris Jr, S M; Cederbaum, S D et al. (2000) Induction of arginase II in human Caco-2 tumor cells by cyclic AMP. Arch Biochem Biophys 374:255-60
Wei, L H; Jacobs, A T; Morris Jr, S M et al. (2000) IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 279:C248-56

Showing the most recent 10 out of 55 publications